Symptoms and complications

The most characteristic symptom of malaria is fever, sometimes alternating with sweating and chills. Generally, the symptoms are non-specific, including headache, muscle pain, fatigue, nausea and vomiting, diarrhoea and cough.

All four malaria parasites can also cause the following symptoms:

  • Anaemia.
  • Low platelet counts (thrombocytopenia).
  • A swollen or tender liver.
  • Jaundice: yellowing of the skin and the whites of the eyes.
  • A tender and enlarged spleen.

Sometimes, the spleen can burst.

P. falciparum can infect a wider variety of red blood cells than other species of parasite, leading to higher parasite burdens, and severe malaria in non-immune individuals. Mortality of severe malaria can exceed 30%.1

Cerebral malaria is a complication of severe malaria caused by infection of the brain. It begins with headaches, an impaired state of consciousness or seizures. Without treatment, symptoms can rapidly progress to coma or death. Even with treatment, a small percentage of those who survive will have persistent neurological abnormalities.

Other complications sometimes seen with severe P. falciparum malaria include fluid in the lungs with breathing problems, low blood sugar levels, bleeding and anaemia requiring blood transfusions, and kidney impairment or failure.

Malaria and pregnancy

Malaria is particularly dangerous to pregnant women. Women who have never acquired immunity may experience acute malaria, loss of pregnancy and stillbirth.

Women from endemic areas may partially lose acquired immunity when they are pregnant. These women usually experience asymptomatic infections but can develop malaria in the placenta that leads to birth retardation, low birth rate and increased infant death rates during delivery. The risk of placental malaria is greatest during the first pregnancy, and much lower during subsequent pregnancies. However, this may not be the case in HIV-positive mothers.

Several studies have found that prenatal exposure to malaria may generate a protective immune response and that infant parasitemia or clinical malaria upregulates chemokine activity that competes with HIV for use of the CCR5 receptor.2 

References

  1. Phillips P et al. Exchange transfusion as an adjunct to the treatment of severe falciparum malaria: case report and review. Rev Infect Dis 12: 1100, 1990
  2. van Eijk AM et al. HIV, malaria, and infant transmission. J Infect Dis 196(1): 30-37, 2007
This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.